Comorbid Chronic Inflammatory Diseases Influence Alopecia Areata Prognosis

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 28, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 28, 2025 -- Comorbid chronic inflammatory diseases (CIDs) influence the prognosis of alopecia areata (AA), according to a research letter published online Jan. 8 in Allergy.

Annika Friedrich, from the University of Bonn in Germany, and colleagues used self-reported data from 2,657 mainly Central European AA patients to conduct a comprehensive analysis of associations between comorbid CIDs and selected AA-clinical features of relevance to prognosis.

Overall, 53.7 percent of the AA cohort reported one or more comorbid CID of any type: 44.5 and 17.4 percent reported one or more comorbid atopic CID and nonatopic CID, respectively. The researchers found that compared with patients with no comorbid CIDs, those with comorbid atopic dermatitis (AD), bronchial asthma, or Hashimoto thyroiditis were significantly more likely to report early-onset, severe, and prolonged AA. A significantly increased risk for prolonged AA was seen for patients with comorbid rhinitis or vitiligo. Compared with comorbid AD or rhinitis, comorbid bronchial asthma was associated with a higher risk for early-onset, severe, or prolonged AA. A more pronounced association was seen for CID comorbidity status with AA duration than with age of onset or severity. A significantly higher number of self-reported atopic comorbidities was seen in early-onset, severe, and prolonged AA compared with late-onset, mild, and nonprolonged disease, respectively. Per additional atopic comorbidity, the odds of early-onset, severe, and prolonged AA increased by 1.179, 1.130, and 1.202, respectively. The mean age of onset for AA was almost 10 years earlier in patients with AD + bronchial asthma + rhinitis compared with patients with AA only.

"Our findings suggest that distinct comorbid constellations may indicate AA subtypes with differing prognoses," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-29 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords